- The Director-General for Healthcare Services at the Ministry of Health has issued Circular No. HK.02.02/III/3887/2022 on the Obligation for Healthcare Facilities to Report Congenital Hypothyroid ("HK") Screening Results for Newborn Infants ("Circular 3887/2022"), which requires all healthcare facilities that offer birthing facilities to take infant blood samples and to send them to HK screening laboratories. This new framework has been in force since 7 December 2022.
- Mandatory HK screening comes into effect from 1 December 2022, while weekly reports should be submitted through the following site: https://link.kemkes.go.id/PelaporanSHK. In this regard, in addition to the taking of blood samples from infants and sending them to laboratories, healthcare facilities must also monitor the results of the laboratory testing of infants with high levels of TSH, carry out confirmation tests on such infants and must refer said infants to pediatricians. Confirmation tests must be administered within seven days of any first test results being issued by laboratories.
- Laboratories that implement the confirmation testing of blood samples must inform the relevant healthcare facilities of any positive test results within 24 hours of said confirmation test blood samples being received. If positive test results confirm that infants have HK then said infants must be treated by pediatricians who administer hormone replacement therapy through the prescribing of thyroxin pills. It is recommended that such therapy should commence when the relevant infants are less than 30 days old.
......
Subscribe to read more legal analysis.
Hukumonline Pro Intelligence
Platform AI hukum terpercaya sebagai solusi komprehensif riset Anda
*Syarat dan ketentuan berlaku
Ada Pertanyaan? Hubungi Kami 
Professional Solutions
University Solutions
Pro
My Workspace
Pro AI
Terfavorit
Allex QnA
Pro Compliance
